4,121 reports of this reaction
3.9% of all METFORMIN HCL reports
#3 most reported adverse reaction
WEIGHT DECREASED is the #3 most commonly reported adverse reaction for METFORMIN HCL, manufactured by Ascend Laboratories, LLC. There are 4,121 FDA adverse event reports linking METFORMIN HCL to WEIGHT DECREASED. This represents approximately 3.9% of all 105,459 adverse event reports for this drug.
Patients taking METFORMIN HCL who experience weight decreased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
WEIGHT DECREASED is moderately reported among METFORMIN HCL users, representing a notable but not dominant share of adverse events.
In addition to weight decreased, the following adverse reactions have been reported for METFORMIN HCL:
The following drugs have also been linked to weight decreased in FDA adverse event reports:
WEIGHT DECREASED has been reported as an adverse event in 4,121 FDA reports for METFORMIN HCL. This does not prove causation, but indicates an association observed in post-market surveillance data.
WEIGHT DECREASED accounts for approximately 3.9% of all adverse event reports for METFORMIN HCL, making it one of the most commonly reported side effect.
If you experience weight decreased while taking METFORMIN HCL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.